Zoetis Inc. $ZTS Shares Sold by Oregon Public Employees Retirement Fund

Oregon Public Employees Retirement Fund lessened its stake in shares of Zoetis Inc. (NYSE:ZTS) by 0.3% in the second quarter, according to its most recent filing with the SEC. The fund owned 38,414 shares of the company’s stock after selling 100 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Zoetis were worth $5,991,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of ZTS. Nova Wealth Management Inc. acquired a new stake in Zoetis during the 1st quarter worth about $25,000. 1248 Management LLC purchased a new position in shares of Zoetis in the first quarter worth approximately $27,000. Saudi Central Bank acquired a new stake in shares of Zoetis during the first quarter valued at approximately $29,000. Cornerstone Planning Group LLC lifted its position in shares of Zoetis by 79.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock valued at $30,000 after acquiring an additional 88 shares in the last quarter. Finally, REAP Financial Group LLC lifted its position in shares of Zoetis by 201.5% in the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock valued at $31,000 after acquiring an additional 131 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ZTS has been the topic of several recent analyst reports. Argus reissued a “buy” rating and set a $190.00 target price on shares of Zoetis in a research note on Tuesday, September 9th. Leerink Partnrs downgraded Zoetis from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 17th. Piper Sandler increased their price objective on Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. Leerink Partners lowered Zoetis from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. Finally, Stifel Nicolaus downgraded Zoetis from a “buy” rating to a “hold” rating and dropped their target price for the company from $165.00 to $160.00 in a report on Wednesday, June 18th. Four research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, Zoetis presently has an average rating of “Hold” and an average target price of $196.71.

Zoetis Stock Performance

Shares of NYSE ZTS opened at $142.29 on Tuesday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. Zoetis Inc. has a one year low of $139.34 and a one year high of $196.55. The business’s 50-day moving average price is $149.04 and its two-hundred day moving average price is $154.19. The company has a market capitalization of $63.06 billion, a P/E ratio of 24.49, a price-to-earnings-growth ratio of 2.26 and a beta of 0.90.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.62 by $0.14. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the previous year, the business posted $1.56 EPS. The firm’s quarterly revenue was up 4.2% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, October 31st. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. Zoetis’s dividend payout ratio is 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.